Literature DB >> 12190182

Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.

Luke J Murtagh1, Michael Whiley, Susan Wilson, Huy Tran, Mark L Bassett.   

Abstract

OBJECTIVE: Unsaturated iron binding capacity (UIBC) has been proposed as an inexpensive alternative to transferrin saturation for detection of hereditary hemochromatosis. The aim of this study was to compare, in a hospital referral clinic, the reliability of transferrin saturation and UIBC for detection of subjects who have inherited HFE (HLA-asociated iron overload) genotypes predisposing to iron overload.
METHODS: Serum transferrin saturation, UIBC, and ferritin were tested in 110 consecutive subjects. Optimum thresholds were determined from receiver operating characteristic curves.
RESULTS: Of 110 subjects, 44 carried significant HFE mutations (C282Y/C282Y or C282Y/H63D). In genetically predisposed subjects with biochemical expression, the optimum threshold for transferrin saturation was 43%, giving a sensitivity of 0.88 and specificity 0.95. For UIBC, the optimum threshold was 143 microg/dL (25.6 micromol/L), giving a sensitivity of 0.91 and specificity of 0.95. In patients referred with a family history or clinical suspicion of hemochromatosis, transferrin saturation and UIBC were highly reliable predictors of genotype. In patients referred for investigation of abnormal liver enzymes without a known family history of hemochromatosis, a normal transferrin saturation or normal UIBC was highly reliable in excluding hemochromatosis.
CONCLUSIONS: Transferrin saturation and UIBC have equal reliability in ability to predict hemochromatosis. UIBC should be considered as an alternative to transferrin saturation in detection of hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190182     DOI: 10.1111/j.1572-0241.2002.05927.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

1.  The diagnosis and management of hereditary haemochromatosis.

Authors:  Paul Clark; Laurence J Britton; Lawrie W Powell
Journal:  Clin Biochem Rev       Date:  2010-02

2.  An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.

Authors:  Jelena Rascon; Lina Rageliene; Sigita Stankeviciene; Darius Palionis; Algirdas Edvardas Tamosiunas; Nomeda Valeviciene; Tadas Zvirblis
Journal:  Eur J Pediatr       Date:  2014-09       Impact factor: 3.183

3.  Evaluation of the mobile phone electromagnetic radiation on serum iron parameters in rats.

Authors:  Murat Çetkin; Can Demirel; Neşe Kızılkan; Nur Aksoy; Hülya Erbağcı
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

4.  Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.

Authors:  Subhashini Chandrasekharan; Emily Pitlick; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

5.  An efficient machine learning-based approach for screening individuals at risk of hereditary haemochromatosis.

Authors:  Patricia Martins Conde; Thomas Sauter; Thanh-Phuong Nguyen
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.